CMMBVSDNA• 3 Months (Normalized)
CMMB vs DNA (Chemomab Therapeutics Ltd. vs Ginkgo Bioworks Holdings Inc.)
Showing Closing Date Range from Jul 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CMMB Performance $1.67
-26.43%
Chemomab Therapeutics Ltd.
Normalized Baseline0.00%
DNA Performance $10.46
+%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
-26.43 pts
DNA outperforming by 26.43 percentage points
CMMBDNA
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CMMB DNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | CMMB Price | CMMB Gain (%) | DNA Price | DNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $1.67 | -26.43% | $- | - | |
| Sep 28, 2026 | $1.64 | -27.75% | $10.46 | +0.58% | -28.33% |
| Sep 25, 2026 | $2.16 | -4.85% | $10.66 | +2.50% | -7.35% |
| Sep 24, 2026 | $2.20 | -3.08% | $10.25 | -1.44% | -1.64% |
| Sep 23, 2026 | $2.28 | +0.44% | $8.58 | -17.50% | +17.94% |
| Sep 22, 2026 | $2.51 | +10.57% | $9.37 | -9.90% | +20.47% |
| Sep 21, 2026 | $2.48 | +9.25% | $7.98 | -23.27% | +32.52% |
| Sep 18, 2026 | $2.61 | +14.98% | $7.88 | -24.23% | +39.21% |
| Sep 17, 2026 | $2.80 | +23.35% | $7.84 | -24.62% | +47.97% |
| Sep 16, 2026 | $2.65 | +16.74% | $7.06 | -32.12% | +48.86% |
| Sep 15, 2026 | $2.47 | +8.81% | $6.99 | -32.79% | +41.60% |
| Sep 14, 2026 | $2.45 | +7.93% | $7.01 | -32.60% | +40.53% |
| Sep 11, 2026 | $2.58 | +13.66% | $6.75 | -35.10% | +48.76% |
| Sep 10, 2026 | $2.60 | +14.54% | $6.78 | -34.81% | +49.35% |
| Sep 09, 2026 | $2.69 | +18.50% | $6.79 | -34.71% | +53.21% |
Page 1 of 5